Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLAME: Fluorometholone as Adjunctive Therapy for TT Surgery
NCT04149210Phase 3Completed
- Sponsor
- Massachusetts Eye and Ear
- Start
- Aug 2021
- Primary completion
- Nov 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluorometholone in trachomatous trichiasis (TT) (2 arms), sponsored by Massachusetts Eye and Ear. Primary endpoint: Incidence of Postoperative Trachomatous Trichiasis at 12 months. Started Aug 2021; status: completed.
02
Drugs
fluorometholone
03
Conditions
trachomatous trichiasis (TT)
Beyond the preview
Go deeper on NCT04149210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04149210.